Newsletter

IGF Leads Genomics Training at International Summer Course on Tropical Biodiversity 2026

IGF Leads Genomics Training at International Summer Course on Tropical Biodiversity 2026

July 22, 2026

IGF served as the genomics training partner for the 2026 International Summer Course on Tropical Biodiversity and Sustainable Development, guiding 57 students and academics from UTS, ANU, and UGM through a full hands-on sequencing workflow: from an introductory bioinformatics session, through lab orientation and DNA extraction, to a sequencing library preparation demo. The genomics track complemented the course's broader program of drone-based geospatial mapping, coastal field sampling, and iNaturalist citizen-science data collection.


IGF and RSA UGM Explore Clinical Genomics Partnership

IGF and RSA UGM Explore Clinical Genomics Partnership

May 22, 2026

IGF and RSA UGM's Clinical Research Unit are exploring a partnership to bring NGS-based clinical genomics testing: from undiagnosed disease diagnostics to pharmacogenomics and precision oncology, to RSA UGM's research ecosystem.


IGF at the INNA Colloquium, BRIN Cibinong

IGF at the INNA Colloquium, BRIN Cibinong

May 19, 2026

IGF represented Faculty of Biology UGM at BRIN's colloquium on international DNA data bank standards and the Indonesian Nucleotide Archive (INNA), followed by a visit to BRIN Cibinong's Genomics Laboratory to explore future sequencing and bioinformatics collaboration


Oxford Nanopore Workshop Opens ICBS 2025

Oxford Nanopore Workshop Opens ICBS 2025

October 16, 2025

IGF and Oxford Nanopore Technologies opened the 9th ICBS 2025 pre-conference series with a hands-on metagenomic library preparation workshop, training around 25 researchers on long-read sequencing from DNA extraction through sample prep.


IGF Joins Precision Medicine Seminar at BB Binomika, Kemenkes RI

IGF Joins Precision Medicine Seminar at BB Binomika, Kemenkes RI

September 16, 2025

IGF joined a Kemenkes RI seminar on Oxford Nanopore adaptive sampling for precision medicine, exploring pharmacogenomics and hereditary cancer applications while discussing potential collaboration to bring PromethION 24 sequencing capacity to national genomic medicine efforts.